← FDA DRUG APPROVALS

FDA ANDA · ANDA204912

TIMOLOL MALEATE

Sponsor: AKORN INC

APPLICATION
ANDA204912
TYPE
ANDA
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION
MARKETING STATUS
None (Tentative Approval)

Products

TIMOLOL MALEATENone (Tentative Approval)
TIMOLOL MALEATE 0.5% · SOLUTION · OPHTHALMIC

Approval history

2015-09-24UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →